ViThera Pharmaceuticals

ViThera Pharmaceuticals is an early stage biotech company located in the life-science cluster at One Kendall Square in Cambridge, MA. Dr. Johannes Fruehauf and the ViThera team brought the first bacteria-based RNAi drug delivery platform to clinical trials and successfully exited for $46M in the company’s third year. ViThera harnesses the synthetic potential of bacteria to produce therapeutic molecules within the body to develop a revolutionary new treatment for Inflammatory Bowel Disease.

Product 1 to 1 of 1

EnLact Probiotics
Medicine from USA by ViThera Pharmaceuticals.